Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastrointestinal dysfunction in neurologic disease

M Camilleri1, A E Bharucha

  • 1Mayo Clinic, GI Unit, Rochester, MN 55905, USA.

Seminars in Neurology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-center Clinical Experience of Diarrhea in Patients Treated With Sorafenib Shows Rare Development of Pancreatic Atrophy.

Gastro hep advances·2024
Same author

Rectal Evacuation Disorders in Patients Presenting With Chronic Functional Diarrhea.

Gastro hep advances·2024
Same author

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome.

Gastro hep advances·2023
Same author

A pharmacological challenge predicts reversible rectal sensorimotor dysfunctions in women with fecal incontinence.

Neurogastroenterology and motility·2018
Same author

Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans.

Neurogastroenterology and motility·2018
Same author

Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms.

Neurogastroenterology and motility·2018
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Gastrointestinal motor dysfunctions arise from nerve damage affecting digestion. Treatments include physical therapy, medication, and novel electrical stimulation for conditions like constipation.

Area of Science:

  • Neurogastroenterology
  • Digestive System Physiology

Background:

  • Gastrointestinal (GI) motor dysfunctions stem from impaired extrinsic autonomic nerve signaling.
  • These dysfunctions affect digestive tract motility, which relies on the enteric nervous system and smooth muscle automaticity.
  • Disorders can occur at any level of extrinsic neural control or involve gut smooth muscle degeneration.

Purpose of the Study:

  • To highlight the nervous system's crucial role in modulating gut motor function.
  • To broaden the understanding of GI symptoms in neurologic disorders beyond dysphagia and constipation.
  • To review available diagnostic and therapeutic strategies for GI motor dysfunctions.

Main Methods:

  • Review of existing literature on GI motor control and dysfunction.
  • Analysis of common and emerging symptoms associated with neurologic disorders.

Related Experiment Videos

  • Evaluation of current therapeutic approaches for GI motility disorders.

    • Main Results:

    • Neurologic disorders can manifest with diverse GI symptoms including incontinence, vomiting, and abdominal distention.
    • Effective therapies are available, tailored to specific dysfunctions.
    • Novel treatments like electrical stimulation show promise for conditions such as paraplegic constipation.

    Conclusions:

    • Understanding extrinsic neural control is key to managing GI motor dysfunctions.
    • A comprehensive approach to diagnosis and therapy is essential for patient care.
    • Emerging technologies offer new hope for refractory GI motility issues.